Dr. Leslie F Mason, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 115 Fountains Blvd, Suite A, Madison, MS 39110 Phone: 601-853-0100 Fax: 601-853-3999 |
Melissa M Bacon, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 113 Mcrae Pt, Madison, MS 39110 Phone: 507-250-7030 |
Dr. Erika Love Tanner, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 115 Fountains Blvd, Suite A, Madison, MS 39110 Phone: 601-853-0100 Fax: 601-853-3999 |
News Archive
An ongoing Phase-II trial investigating a new, targeted therapy for metastatic urothelial cancer has generated promising early results, Italian researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
Phase 2a trial results with KB001 suggest the recombinant, human PEGylated monoclonal antibody fragment, under development by KaloBios Pharmaceuticals, Inc. and Sanofi Pasteur, offers potential as an alternative to antibiotics for preventing or reducing pneumonias in mechanically ventilated intensive care unit (ICU) patients heavily colonized with Pseudomonas aeruginosa (Pa).
Lung cancer is the second most common type of cancer and leading cause of cancer death in men and women, with non-small cell lung cancer (NSCLC) accounting for up to 90% of cases. Somatic mutations heavily impact the sensitivity of NSCLC patients to various drug treatments, and are critical for choosing the most effective targeted therapies for this cancer.
New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest it could be useful for enhancing protection against a number of different infections.
Biopsying the glands that produce saliva to test for germinal center-like formation when someone is diagnosed with primary Sjögren's Syndrome can predict later development of non-Hodgkin's lymphoma, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.
› Verified 5 days ago